X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2008) 2008
Publication (251) 251
Book Review (42) 42
Book Chapter (17) 17
Book / eBook (13) 13
Conference Proceeding (2) 2
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1482) 1482
index medicus (1131) 1131
oncology (1103) 1103
female (676) 676
male (663) 663
clinical neurology (657) 657
glioblastoma (603) 603
middle aged (573) 573
chemotherapy (569) 569
recurrent glioblastoma (568) 568
adult (549) 549
brain neoplasms - drug therapy (526) 526
glioblastoma multiforme (510) 510
cancer (496) 496
aged (470) 470
phase-ii trial (448) 448
temozolomide (443) 443
gliomas (436) 436
medicine & public health (420) 420
radiotherapy (413) 413
brain neoplasms - pathology (390) 390
glioblastoma-multiforme (377) 377
malignant glioma (350) 350
glioma (349) 349
animals (345) 345
brain neoplasms - therapy (333) 333
brain tumors (329) 329
survival (328) 328
bevacizumab (320) 320
surgery (318) 318
care and treatment (317) 317
glioblastoma - drug therapy (317) 317
treatment outcome (317) 317
radiation-therapy (285) 285
tumors (284) 284
recurrent (273) 273
neurology (271) 271
recurrent malignant glioma (266) 266
high-grade gliomas (255) 255
phase-ii (254) 254
recurrent glioblastoma-multiforme (252) 252
glioma - drug therapy (247) 247
antineoplastic agents - therapeutic use (240) 240
prognosis (237) 237
brain-tumors (226) 226
glioblastoma - pathology (225) 225
dacarbazine - analogs & derivatives (222) 222
combined modality therapy (214) 214
brain neoplasms - mortality (210) 210
glioma - pathology (205) 205
malignant gliomas (205) 205
magnetic resonance imaging (196) 196
research (194) 194
newly-diagnosed glioblastoma (191) 191
brain neoplasms - surgery (189) 189
analysis (187) 187
retrospective studies (187) 187
adjuvant temozolomide (186) 186
brain neoplasms - radiotherapy (183) 183
survival analysis (177) 177
adolescent (176) 176
brain cancer (176) 176
glioblastoma - therapy (176) 176
pharmacology & pharmacy (176) 176
clinical trials (174) 174
health aspects (173) 173
radiology, nuclear medicine & medical imaging (172) 172
recurrent malignant gliomas (172) 172
neurosciences (171) 171
glioma - therapy (166) 166
therapy (166) 166
immunotherapy (163) 163
high-grade glioma (161) 161
antineoplastic combined chemotherapy protocols - therapeutic use (154) 154
young adult (152) 152
radiation therapy (149) 149
brain (148) 148
article (144) 144
glioblastoma - mortality (143) 143
central-nervous-system (139) 139
neoplasm recurrence, local - drug therapy (138) 138
development and progression (137) 137
disease-free survival (137) 137
survival rate (136) 136
brain neoplasms - genetics (132) 132
angiogenesis (130) 130
dacarbazine - therapeutic use (130) 130
cell line, tumor (129) 129
drug therapy (129) 129
child (128) 128
patients (128) 128
clinical trials as topic (125) 125
disease progression (125) 125
multiforme (125) 125
trial (122) 122
angiogenesis inhibitors - therapeutic use (121) 121
brain neoplasms - metabolism (120) 120
neurosurgery (120) 120
antineoplastic agents (118) 118
radiation (118) 118
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1995) 1995
German (13) 13
French (9) 9
Japanese (6) 6
Spanish (6) 6
Czech (2) 2
Korean (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Medicinal Chemistry, ISSN 0929-8673, 08/2017, Volume 24, Issue 27, pp. 3002 - 3009
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 01/2017, Volume 37, Issue 1, pp. 21 - 33
Glioblastoma multiforme (GBM) represents the most malignant primary brain tumor in adults with generally dismal prognosis, early clinical deterioration and... 
GBM | Targeted therapy | Immunotherapy | Clinical trials | PD1 inhibition | Immune checkpoint inhibitors | Review | Personalized medicine | Glioblastoma multiforme | CTLA4 inhibition | targeted therapy | NEWLY-DIAGNOSED GLIOBLASTOMA | INTEGRATED GENOMIC ANALYSIS | RECURRENT GLIOBLASTOMA | BEVACIZUMAB PLUS IRINOTECAN | OPEN-LABEL | immune checkpoint inhibitors | personalized medicine | RADIATION-THERAPY | CELL LUNG-CANCER | PHASE-II TRIAL | ONCOLOGY | review | immunotherapy | clinical trials | CENTRAL-NERVOUS-SYSTEM | HIGH-GRADE GLIOMAS | Humans | Antibodies, Monoclonal - adverse effects | Tumor Microenvironment | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Brain Neoplasms - metabolism | Brain Neoplasms - immunology | Molecular Targeted Therapy - trends | Glioblastoma - genetics | Antineoplastic Agents - adverse effects | Immunotherapy - trends | Angiogenesis Inhibitors - therapeutic use | Biomarkers, Tumor - metabolism | Glioblastoma - metabolism | Biomarkers, Tumor - antagonists & inhibitors | Molecular Targeted Therapy - adverse effects | Brain Neoplasms - genetics | Treatment Outcome | Immunotherapy - adverse effects | Glioblastoma - therapy | Animals | Glioblastoma - immunology | Signal Transduction - drug effects | Protein Kinase Inhibitors - therapeutic use | Brain Neoplasms - therapy | Biomarkers, Tumor - genetics | Biomarkers, Tumor - immunology
Journal Article